Candidate

Indication

Status

U.S/Canada rights

Ex-U.S/Canada rights

Evoltra®
Clofarabine
(Clolar®)

Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)

Marketed in U.S. (pediatric)

Filed in E.U. (pediatric)

Genzyme

Bioenvision

Acute Myelogenous Leukemia (AML)

Phase II in E.U. (adult)

Genzyme

Bioenvision

Refractory Chronic Lymphocytic Leukemia (CLL)

Phase II in U.S. (adult)

Genzyme

Bioenvision

Solid Tumors

Phase I (Intravenous)

Genzyme

Bioenvision

Solid Tumors

Phase I (Oral)

Genzyme

Bioenvision

Non-Cancer

Developmental

Bioenvision

Bioenvision

Modrenal®

Breast Cancer

Marketed in U.K. and Germany

Phase IV in U.K.

Phase II in E.U.

Bioenvision

Bioenvision

Prostate Cancer

Phase II in U.S.

Bioenvision

Bioenvision

Suvus®

Hepatitis C

Investigator-Sponsored Phase II in Europe and Middle East

Bioenvision

Bioenvision